Holding · 0.7% · hold (from 0.7%) · large · Technology · last 69.98
Entry 70.50–73.50 · Stop 66.50 · Target 83.00 · Hold (on target)
The long thesis holds, but $69.98 is just below the entry zone and the CEO sold shares. Stop at $66.50.
Thesis (long, position, conviction 64)
Thesis carried over from the 2026-10-13 run.
Bull: Nutanix closed fiscal 2026 with revenue up 12% to $2.85B and ARR up 16% to $2.55B, while GAAP operating margin expanded sharply to 9.6% from 6.8% and free cash flow rose to $840.7M from $750.2M (F-NTNX-1, F-NTNX-2, F-NTNX-3, F-NTNX-4). Q4 showed accelerating momentum (revenue +16%, operating income more than doubling, F-NTNX-5), and management's fiscal 2027 guide of $3.18-3.23B revenue and $850-950M FCF implies continued double-digit growth with further margin/cash conversion gains (F-NTNX-6, F-NTNX-7). Sell-side sentiment is uniformly constructive (4 strong buy, 11 buy, 10 hold, zero sells, F-NTNX-10), and price action confirms the fundamental improvement: the stock trades above its 20/50/200-day moving averages, is only 2.3% off its 52-week high, and has beaten SPY by over 30 points in three months (F-NTNX-8, F-NTNX-9) — a durable uptrend rather than a speculative spike, with RSI at 62 indicating room before overbought extremes.
Bear: The stock has already run 33.5% in three months and sits near its 52-week high, so much of the fundamental improvement may be priced in, leaving a thinner margin of safety if fiscal 2027 execution merely meets rather than beats the guided ranges (F-NTNX-9, F-NTNX-6). GAAP operating margin, while improving, is still modest at 9.6%, so any deceleration in ARR growth (16% in FY26) or opex discipline could compress the premium multiple quickly. CEO Rajiv Ramaswami's reported sale of 400,000 shares on October 8, 2026 is a visible insider-selling data point just before the next earnings report, and the brief cannot confirm whether this was a scheduled 10b5-1 sale or something more discretionary, leaving genuine ambiguity (F-NTNX-11). The brief also lacks company-specific risk disclosure detail and underlying valuation multiples (P/E, EV/FCF relative to peers), so the bull case rests on momentum and guidance rather than a fully verified valuation anchor.
Valuation: The brief does not supply a market cap, share count, or peer multiples, so an explicit P/E or EV/FCF comparison isn't possible from the data given. On FY26 FCF of $840.7M against FY27 guidance of $850-950M, the business is compounding free cash flow at low-double-digit rates alongside 12-16% top-line growth and expanding GAAP margins — a profile that generally supports a premium multiple, but without concrete valuation multiples in the brief, this is a qualitative read, not a quantified value call.
Catalysts
2026-11-23: Fiscal 2027 Q1 earnings report, with company guidance of $755-765M revenue and 26-28% non-GAAP operating margin against a street estimate near $784.4M revenue
Facts
F-NTNX-1: For fiscal 2026, ended July 31, 2026, Nutanix reported revenue of $2.85 billion, up 12% year over year. (as of 2026-08-26)[E5429]source
F-NTNX-2: Fiscal 2026 annual recurring revenue was $2.55 billion, up 16% year over year. (as of 2026-08-26)[E5429]source
F-NTNX-3: Fiscal 2026 GAAP operating income was $274.0 million, compared with $172.5 million in fiscal 2025; GAAP operating margin increased to 9.6% from 6.8%. (as of 2026-08-26)[E5429]source
F-NTNX-4: Fiscal 2026 free cash flow was $840.7 million, compared with $750.2 million in fiscal 2025. (as of 2026-08-26)[E5429]source
F-NTNX-5: In the fourth quarter of fiscal 2026, revenue was $757.1 million, up 16% year over year, and GAAP operating income was $70.0 million versus $31.2 million a year earlier. (as of 2026-08-26)[E5429]source
F-NTNX-6: Management's fiscal 2027 outlook calls for revenue of $3.180–$3.230 billion and free cash flow of $850–$950 million. (as of 2026-08-26)[E5429]source
F-NTNX-7: The fiscal 2027 first-quarter revenue outlook was $755–$765 million; the company also projected a 26%–28% non-GAAP operating margin for that quarter. (as of 2026-08-26)[E5429]source
F-NTNX-8: NTNX closed at $72.88 on October 13, 2026, above its 20-day, 50-day, and 200-day moving averages of $71.10, $68.07, and $51.29, respectively. (as of 2026-10-13)[E4729]
F-NTNX-9: As of October 13, 2026, the shares were 2.34% below their 52-week closing high; the 3-month return was 33.5%, and relative strength versus SPY over that period was 30.17%. (as of 2026-10-13)[E4729]
F-NTNX-10: The September 2026 analyst recommendation tally was 4 strong buy, 11 buy, 10 hold, and no sell or strong sell recommendations. (as of 2026-09-01)[E4754, E5420]
F-NTNX-11: A news report dated October 8, 2026, said CEO Rajiv Ramaswami sold 400,000 shares; the supplied materials do not establish the transaction's circumstances. (as of 2026-10-08)[E4745]source
What would change the view
A confirmed Form 4 showing the CEO sale was discretionary and tied to a pattern of insider selling, not a 10b5-1 plan
A close below $66.50 on volume, breaking the stop and invalidating the uptrend thesis
Fiscal Q1 FY27 results or guidance below the low end of the $755-765M revenue range
Data quality
Quality score 96/100.
Gap: The quote block is dated October 14, 2026, after the context's stated date of October 13, 2026; the October 13 closing price from the daily bars is used instead.
Gap: The supplied annual filing excerpt provides the 10-K's contents and general forward-looking-statement language, but not enough detail to assess company-specific risk disclosures.
Gap: The reported insider sale is based on a news snippet; the supplied materials do not include the underlying Form 4 transaction details.
Red flag: A news report said the CEO sold 400,000 shares on October 8, 2026; the supplied evidence does not clarify whether the sale was scheduled or its relationship to the CEO's remaining ownership.